OncoMed to Present Data on Multiple Anti-Cancer Stem Cell Candidates at the …NasdaqREDWOOD CITY, Calif., March 19, 2015 (GLOBE NEWSWIRE) — OncoMed Pharmaceuticals Inc. (Nasdaq:OMED) will present new data related to its clinical and preclinical anti-… Continue reading
TheHorse.com |
The ABCs of Stem Cells and Regenerative Medicine for Horses
TheHorse.com “There are many types and varieties of stem cells, growth factors, what have you.” Equine researchers indeed have been studying, using, and learning more about everything from MSCs to PRP and ACS to BMPs—don’t worry, we’ll explain later—all with a … |
|
Will Stem Cell Profits Measure Up?: NxR Biotechnologies’ Alain Vertès
Seeking Alpha (registration) The market is still not valuing stem cell programs and companies fairly; this is a very exciting time for proposed stem cell therapies. Hopefully, with the accelerated pathway we’re seeing in Japan, novel therapeutics will take a lot less time to get … |
The Indian Express |
Stem cell therapy helps US girl regain mobility, speech
Times of India A year ago, 20-year-old Christie from Mississippi could not stand, walk or eat by herself. She was diagnosed with cerebellar ataxia — lack of muscle control due to damage, degeneration or loss of nerve cells in the part of the brain that controls … Wheelchair-bound US girl, treated in city, now a swimming champThe Indian Express Mumbai connection to US swimmer’s medal-winning effort at Special OlympicsMid-Day |
The Indian Express |
Stem cell therapy helps US girl regain mobility, speech
Times of India A year ago, 20-year-old Christie from Mississippi could not stand, walk or eat by herself. She was diagnosed with cerebellar ataxia — lack of muscle control due to damage, degeneration or loss of nerve cells in the part of the brain that controls … Wheelchair-bound US girl, treated in city, now a swimming champThe Indian Express Mumbai connection to US swimmer’s medal-winning effort at Special OlympicsMid-Day |
|
Optimistic Stem Cell Quotes
Corante How does the press cover stem cell work? You probably already know the answer to that one, but here’s proof: this paper examines the media coverage from 2010 to 2013, and finds that “highly optimistic” timelines for translation to the clinic are the rule. |